PPMD Duchenne Compass Meeting report

The Duchenne Patient-Focused Compass Meeting was held as part of FDA’s Patient-Focused Drug Development (PFDD) initiative. As an externally led meeting, it was hosted and planned by Parent Project Muscular Dystrophy (PPMD) in collaboration with FDA and a Community Advisory Board com- prised of leaders of 14 independent Duchenne patient advocacy organizations.

Federal partners from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid (CMS), Social Security Administration (SSA), Department of Education, Department of Labor, and Department of Defense also attended. Representatives from industry, including members of PPMD’s Duchenne Drug Discovery Roundtable, health insurance plans, and other stakeholders were present on-site and via the live webcast.